Bash Lori D, Weitzman Dahlia, Blaustein Robert O, Sharon Ofer, Shalev Varda, Chodick Gabriel
Merck & Co., Inc., Kenilworth, NJ USA.
Maccabitech, Maccabi Healthcare Services, Tel-Aviv, Israel.
Isr J Health Policy Res. 2017 Jun 5;6:26. doi: 10.1186/s13584-017-0149-0. eCollection 2017.
Congestive heart failure (CHF) is among the most common causes of hospital admissions and readmissions in the Western world. However, the burden of ambulatory care has not been as well investigated. The objective of this study was to assess the relative burden and direct medical costs of CHF including inpatient and outpatient care.
We used longitudinal clinical data from a two-million member health organization in Israel (Maccabi Healthcare Services) to identify adults with newly diagnosed CHF between January 2006 and December 2012, either in the in- or outpatient setting. Adults without CHF were age- and sex-matched to CHF patients and healthcare utilization and all modes of healthcare costs were compared among them, excluding those in their last year of life.
The burden posed by 6592 CHF patients was significantly ( < 0.001) larger than that of 32,960 matched controls. CHF patients had significantly higher rates of baseline comorbidity and healthcare utilization compared to non-CHF controls. This was evident in all categories of healthcare services and expenses, including in- and outpatient visits, laboratory expenses, medication costs, among younger and older, men and women. Among those who incurred any healthcare costs, younger (45-64y) and older (65 + y) subjects with CHF were observed to have about 3.25 (95% CI: 2.96-3.56) and 2.08 (95% CI: 1.99-2.17) times the healthcare costs, respectively, compared to subjects without CHF after adjusting for patient characteristics.
CHF is associated with an overall two- to three-fold higher cost of healthcare services depending on patient age, accounting for over half of all healthcare costs incurred by elderly CHF patients, and more than two-thirds of all costs among younger CHF patients. Observations of the large burden posed on one of the youngest societies in the developed world are profound, implicative of great opportunities to control the costs of CHF. Further research to understand how resource use impacts health outcomes and quality of care is warranted.
充血性心力衰竭(CHF)是西方世界住院和再入院的最常见原因之一。然而,门诊护理的负担尚未得到充分研究。本研究的目的是评估CHF的相对负担和直接医疗费用,包括住院和门诊护理。
我们使用了以色列一个拥有两百万会员的健康组织(马卡比医疗服务公司)的纵向临床数据,以识别2006年1月至2012年12月期间新诊断为CHF的成年人,无论是在住院还是门诊环境中。无CHF的成年人在年龄和性别上与CHF患者匹配,并比较他们之间的医疗保健利用率和所有医疗费用模式,排除生命最后一年的患者。
6592例CHF患者造成的负担明显(<0.001)大于32960例匹配对照。与非CHF对照相比,CHF患者的基线合并症和医疗保健利用率明显更高。这在所有医疗服务和费用类别中都很明显,包括门诊和住院就诊、实验室费用、药物成本,在年轻人和老年人、男性和女性中都是如此。在产生任何医疗费用的人群中,调整患者特征后,年轻(45 - 64岁)和老年(65岁及以上)的CHF患者的医疗费用分别约为无CHF患者的3.25倍(95% CI:2.96 - 3.56)和2.08倍(95% CI:1.99 - 2.17)。
根据患者年龄,CHF与医疗服务总成本高出两到三倍相关,占老年CHF患者所有医疗费用的一半以上,占年轻CHF患者所有费用的三分之二以上。对这个发达国家中最年轻的社会之一造成的巨大负担的观察意义深远,这意味着控制CHF成本有很大机会。有必要进一步研究以了解资源使用如何影响健康结果和护理质量。